Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
24,183
Sort by:
Human DNA Vaccine Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Route of Administration (Intramuscular, Subcutaneous, Intradermal, Others), By Application (Oncology, Tuberculosis, HIV, Others), By End User (Hospitals & Clinics, Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Human DNA Vaccine Market is projected for substantial growth, expanding from USD 371.02 Million in 2025 to USD 581.28 Million by 2031, demonstrating a CAGR of 7.77%. These advanced immunizi...
May 2026
189 pages
Penicillin Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product (Bulk, Dosage), By Type (Aminopenicillin, Antipseudomonal Penicillin, Beta Lactamase Inhibitor, Others), By Route of Administration (Oral, Intramuscular, Intravenous), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutions), By Region & Competition, 2021-2031F
US$ 4,500.00
The global penicillin market is projected to expand from USD 10.43 Billion in 2025 to USD 13.21 Billion by 2031, demonstrating a compound annual growth rate (CAGR) of 4.02%. Penicillin, a group of bet...
May 2026
188 pages
RNA Targeting Small Molecule Drug Discovery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Cancer, Infectious Diseases, Metabolic Diseases, Neurological Diseases, Others), By End Users (Pharmaceutical and Biopharmaceutical Companies, Academic and Research Institutes, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global RNA Targeting Small Molecule Drug Discovery Market is projected to expand significantly, growing from USD 1.95 Billion in 2025 to USD 6.47 Billion by 2031, at a Compound Annual Growth Rate...
May 2026
188 pages
Medical Cannabis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Buds/Marijuana Flower, Cannabis Extracts), By Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Others), By Distribution Channel (B2B, B2C), By Application (Chronic Pain, Mental Disorders, Cancer, Epilepsy, Others), By End User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Medical Cannabis Market is anticipated to experience substantial growth, expanding from USD 28.81 Billion in 2025 to USD 90.82 Billion by 2031 at a CAGR of 21.09%. This market involves the...
May 2026
180 pages
Muscle Relaxant Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Skeletal Muscle Relaxant Drugs, Facial Muscle Relaxant Drugs, Neuromuscular Blocking Agents), By Route of Administration (Oral, Injectable, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The global muscle relaxant drugs market is projected to expand from USD 4.15 Billion in 2025 to USD 5.38 Billion by 2031, exhibiting a 4.42% Compound Annual Growth Rate. These pharmaceutical agents ar...
May 2026
182 pages
Virtual Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Study Design (Interventional, Observational, Expanded Access), By Indication (Oncology, Cardiovascular Disease, Others), By Phase (Phase 1, Phase 2, Phase 3, Phase 4), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Virtual Clinical Trials Market is projected to expand significantly, growing from USD 8.79 Billion in 2025 to USD 16.46 Billion by 2031, demonstrating an 11.02% CAGR. This market is charact...
May 2026
180 pages
Haemophilia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Haemophilia A, Haemophilia B, Haemophilia C), By Product (Recombinant Coagulation Factor Concentrates, Plasma Derived Coagulation Factor Concentrate, Desmopressin, Antifibrinolytics Agents), By Treatment (On-demand and Prophylaxis), By Therapy (Replacement Therapy, ITI therapy and Gene Therapy), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Haemophilia Treatment Market is projected to expand from USD 12.03 Billion in 2025 to USD 16.82 Billion by 2031, registering a CAGR of 5.75%. Treatment methodologies include replacement the...
May 2026
180 pages
Pharmaceutical Dissolution Testing Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Services Method (In vitro, In vivo), By Dissolution Apparatus (Basket, Paddle, Others), By Dosage Form (Capsule, Tablets, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Pharmaceutical Dissolution Testing Services Market is forecast to expand significantly, from USD 761.39 Million in 2025 to USD 1257.37 Million by 2031, at an 8.72% CAGR. These services invo...
May 2026
180 pages
Addison’s Disease Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Primary Adrenal Insufficiency, Secondary Adrenal Insufficiency, Tertiary Adrenal Insufficiency), By Drug Class (Oral Corticosteroid, Corticosteroid Injections, Sodium Intake), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Addison's Disease Market is anticipated to grow from USD 546.23 Million in 2025 to USD 809.68 Million by 2031, achieving a Compound Annual Growth Rate (CAGR) of 6.78%. This market primarily...
May 2026
180 pages
Andersen-Tawil Syndrome Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Type 1, Type 2), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for Andersen-Tawil Syndrome is projected to expand from USD 2.78 billion in 2025 to USD 4.25 billion by 2031, demonstrating a compound annual growth rate of 7.33%. This market primar...
May 2026
182 pages
Ankylosing Spondylitis Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug (Cosentyx, Humira, Simponi, Remicade, Enbrel, Cimzia), By End Use (Hospitals, Clinics, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for Ankylosing Spondylitis therapeutics is projected to expand significantly, rising from USD 7.88 Billion in 2025 to USD 11.27 Billion by 2031, at a Compound Annual Growth Rate of 6...
May 2026
182 pages
Clinical Trials Matching Software Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Deployment Mode (Web & Cloud-based, On-premises), By End-use (Pharmaceutical & Biotechnology Companies, CROs, Medical Device Firms), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Clinical Trials Matching Software Market is poised for substantial growth, projected to increase from USD 196.23 Million in 2025 to USD 327.11 Million by 2031, at an 8.89% CAGR. This specia...
May 2026
185 pages
Hemophilia A Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Factor Replacement Therapy, Non-Factor Replacement Therapies, Gene Therapy), By Route of Administration (Intravenous, Oral, Nasal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Hemophilia A Treatment Market is projected for significant growth, expanding from USD 14.73 Billion in 2025 to USD 21.44 Billion by 2031, representing a Compound Annual Growth Rate (CAGR) o...
May 2026
185 pages
Hyperuricemia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Primary, Secondary), By Drug Type (Xanthine Oxidase Inhibitors, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The global hyperuricemia market, which includes urate-lowering therapeutics and diagnostic tools for managing elevated serum uric acid, is projected to expand from USD 4.78 billion in 2025 to USD 7.13...
May 2026
185 pages
Iron Deficiency Anemia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy Type (Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion, Others), By Therapy Areas (Obstetrics and Gynecology, Oncology, Congestive Heart Failure (CHF), Inflammatory Bowel Disease, Renal, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Iron Deficiency Anemia Market, comprising therapeutic solutions like oral and parenteral iron formulations aimed at replenishing iron stores and normalizing hemoglobin levels, is projected...
May 2026
180 pages
Non-Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Study Type (Pharmacodynamics (PD) studies, Pharmacokinetics (PK) studies, Toxicology studies), By Test (In silico, In vitro, In vivo), By Therapeutic Area (Oncology, Cardiovascular, Neurology, Immunology, Others), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Government Research Institutes, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Non-Clinical Trials Market is forecast to grow from USD 11.23 Billion in 2025 to USD 16.65 Billion by 2031, achieving a 6.78% CAGR, as these essential in vitro and in vivo studies evaluate...
May 2026
180 pages
Opioid Use Disorder Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Agonist Drugs, Antagonist Drugs, Others), By Route of Administration (Oral, Parenteral, Sublingual, Nasal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Opioid Use Disorder (OUD) Drugs Market is projected to expand robustly from USD 3.89 Billion in 2025 to USD 6.81 Billion by 2031, at a Compound Annual Growth Rate of 9.78%. This market enco...
May 2026
180 pages
Rheumatology Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Ankylosing Spondylitis, Gout, Osteoarthritis, Psoriatic Arthritis, Rheumatoid Arthritis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Rheumatology Therapeutics Market is projected to expand from USD 49.68 Billion in 2025 to USD 58.19 Billion by 2031, demonstrating a compound annual growth rate (CAGR) of 2.67%. This market...
May 2026
182 pages
Rosai-Dorfman Disease Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Classic (nodal) Rosai-Dorfman disease, Extranodal Rosai-Dorfman disease), By Procedure Type (Diagnosis, Treatment), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global Rosai-Dorfman Disease (RDD) market is projected to expand from USD 533.12 billion in 2025 to USD 772.22 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 6.37%. RDD is a r...
May 2026
182 pages
Systemic Juvenile Idiopathic Arthritis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Drug Treatment {Anti-inflammatories (NSAIDS), Tumor Necrosis Factor (TNF) Blockers, Muscle Relaxants, Immune Suppressants Drugs, Disease Modifying Antirheumatic Drugs, Others}, Biologics, Other), By Route of Administration (Oral, Injectables, Other), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Systemic Juvenile Idiopathic Arthritis Market is projected to expand from USD 1.93 Billion in 2025 to USD 2.31 Billion by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 3.04%. Sys...
May 2026
185 pages
Xerostomia Therapeutics Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (OTC, Prescription), By Product (Salivary Stimulants, Salivary Substitutes, Dentifrices), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Xerostomia Therapeutics Market is projected to expand from USD 2.74 Billion in 2025 to USD 3.47 Billion by 2031, exhibiting a Compound Annual Growth Rate (CAGR) of 4.02%. These therapeutics...
May 2026
192 pages
Acquired Orphan Blood Diseases Therapeutics Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy (Recombinant Factor, Immunoglobulin Infusion Therapy, Activated Prothrombin Complex Concentrate, Thrombopoietin Receptor Agonists, Others), By Disease Indication (Acquired Agranulocytosis, Acquired Hemophilia, Acquired Von Willebrand Syndrome, Paroxysmal Nocturnal Hemoglobinuria (PNH), Myelodysplastic Syndrome, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for therapeutics targeting acquired orphan blood diseases is projected to expand significantly, from USD 8.13 billion in 2025 to USD 12.82 billion by 2031, demonstrating a compound a...
May 2026
182 pages
Bacterial Vaccines Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Vaccine Type (Pertussis (Whooping Cough) Vaccines, Tetanus Vaccines, Diphtheria Vaccines, Pneumococcal Vaccines, Meningococcal Vaccines, Typhoid Vaccines, Tuberculosis (TB) Vaccines, Cholera Vaccines, Shigellosis Vaccines, Others), By Patient Age Group (Pediatric Vaccines (Infants, Children), Adolescent Vaccines, Adult Vaccines, Geriatric Vaccines), By Distribution Channel (Government Agencies and Programs, Hospitals and Clinics, Retail Pharmacies, Online Pharmacies, Others) , By Route of Administration (Injectable Vaccines, Oral Vaccines, Nasal Vaccines), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Bacterial Vaccines Market is projected to expand from USD 7.19 billion in 2025 to USD 10.94 billion by 2031, achieving a 7.25% CAGR. Bacterial vaccines are biological agents designed to sti...
May 2026
185 pages
Bulk Drug Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Type (Antibiotics, Sulpha Drugs, Vitamins, Steroids, Analgesics, Others), By End-User (Pharmaceuticals, Biotechnology, Veterinary Medicine), By Region & Competition, 2021-2031F
US$ 4,500.00
The global bulk drug market, encompassing Active Pharmaceutical Ingredients (APIs), is projected for substantial growth, expanding from USD 465.12 billion in 2025 to USD 925.96 billion by 2031 with a...
May 2026
182 pages
Chronic Pain Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Neuropathic Pain, Analgesic Infusion, Ablation), By Product Type (Drugs, Devices), By Distribution Channel (Hospital & Clinics, Ambulatory Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Chronic Pain Treatment Market is projected to expand significantly, rising from USD 86.23 Billion in 2025 to USD 136.53 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) o...
May 2026
180 pages
Fabry Disease Treatment Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drugs (Agalsidase Beta, Migalastat, Others), By Treatment (Enzyme Replacement Therapy (ERT), Chaperone Treatment, Substrate Reduction Therapy (SRT), others), By Route of Administration (Oral, Parenteral, others), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Fabry Disease Treatment Market is projected to expand from USD 1.94 Billion in 2025 to USD 2.81 Billion by 2031, demonstrating a compound annual growth rate (CAGR) of 6.37%. This market foc...
May 2026
185 pages
Heparin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Low Molecular Weight Heparin (LMWH), Ultra-Low Molecular Weight Heparin (ULMWH), By Application (Venous Thromboembolism, Coronary Artery Disease, Renal Impairment, Atrial Fibrillation, Others), By Route of Administration (Intravenous, Subcutaneous), By End Use (Hospitals & Clinics, Ambulatory care Centers, Others) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Heparin Market is projected to expand from USD 6.56 Billion in 2025 to USD 9.34 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 6.07%. Heparin, an injectable anticoag...
May 2026
185 pages
Lysosomal Storage Diseases Therapeutics Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy, others), By Indication (Gaucher's Disease, Fabry Disease, Pompe's Disease, Mucopolysaccharidosis, others), By End User (Hospitals, Clinics), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Lysosomal Storage Diseases Therapeutics Market is projected to expand from USD 7.69 Billion in 2025 to USD 11.72 Billion by 2031, demonstrating a compound annual growth rate (CAGR) of 7.28%...
May 2026
182 pages
Metabolic Disorders Therapeutics Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Disease Type (Lysosomal Storage Diseases, Diabetes, Obesity, Inherited Metabolic Disorders, Hypercholesterolemia, Others), By Therapy Type (Enzyme Replacement Therapy, Cellular Transplantation, Small Molecule Based Therapy, Substrate Reduction Therapy, Gene Therapy, Drug Therapy), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Metabolic Disorders Therapeutics Market is projected for substantial growth, expanding from USD 74.81 Billion in 2025 to USD 116.88 Billion by 2031, at a Compound Annual Growth Rate of 7.72...
May 2026
185 pages
